K.S. Lau

524 total citations
22 papers, 403 citations indexed

About

K.S. Lau is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, K.S. Lau has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in K.S. Lau's work include Thyroid Disorders and Treatments (4 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). K.S. Lau is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). K.S. Lau collaborates with scholars based in Hong Kong, China and Australia. K.S. Lau's co-authors include Annie W. C. Kung, Annie W.C. Kung, Vivian Chan, Victor Herbert, A W Kung, G.C.Y. Fong, Leonard D. Kohn, Jeffrey C. White, Anirban Mukherjee and B H Toh and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Endocrinology.

In The Last Decade

K.S. Lau

22 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.S. Lau Hong Kong 11 159 105 67 62 58 22 403
Patrizia Di Fulvio Italy 11 169 1.1× 110 1.0× 37 0.6× 98 1.6× 21 0.4× 13 481
S. Yumita Japan 9 115 0.7× 24 0.2× 43 0.6× 69 1.1× 40 0.7× 15 434
Nobuo Kotajima Japan 11 122 0.8× 94 0.9× 29 0.4× 65 1.0× 27 0.5× 24 506
Anna‐Lena Eriksson Sweden 11 121 0.8× 98 0.9× 21 0.3× 30 0.5× 109 1.9× 11 441
Laura Fazzuoli Italy 12 92 0.6× 133 1.3× 20 0.3× 12 0.2× 85 1.5× 32 481
H Nihei Japan 10 242 1.5× 14 0.1× 38 0.6× 44 0.7× 70 1.2× 17 428
Katharina I. Blankenstein Germany 7 260 1.6× 106 1.0× 19 0.3× 17 0.3× 68 1.2× 7 418
María G. Ledesma-Colunga Mexico 14 163 1.0× 55 0.5× 25 0.4× 22 0.4× 15 0.3× 25 434
F. Archambeaud France 11 124 0.8× 180 1.7× 47 0.7× 43 0.7× 60 1.0× 18 563
Naoko Amano Japan 12 281 1.8× 185 1.8× 29 0.4× 40 0.6× 40 0.7× 41 507

Countries citing papers authored by K.S. Lau

Since Specialization
Citations

This map shows the geographic impact of K.S. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.S. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.S. Lau more than expected).

Fields of papers citing papers by K.S. Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.S. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.S. Lau. The network helps show where K.S. Lau may publish in the future.

Co-authorship network of co-authors of K.S. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of K.S. Lau. A scholar is included among the top collaborators of K.S. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.S. Lau. K.S. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Victor, et al.. (2019). Differences Between the East and the West in Managing Advanced-Stage Non-small Cell Lung Cancer. Clinical Oncology. 32(1). e1–e9. 7 indexed citations
2.
Chiang, Chi‐Leung, Cheuk‐Wai Choi, Bob Chan, et al.. (2019). Real‐world treatment patterns and outcomes in refractory metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology. 15(S2). 5–13. 6 indexed citations
3.
Lau, K.S., et al.. (2015). 150PD Discordant RAS status between primary and metastatic colorectal cancer and predicted pattern of metastases. Annals of Oncology. 26. ix42–ix42. 1 indexed citations
4.
Xiao, Su‐Mei, Yi Gao, Ching‐Lung Cheung, et al.. (2012). Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Osteoporosis International. 23(7). 1877–1887. 22 indexed citations
5.
Cheung, Ching‐Lung, Gang Li, K.S. Lau, et al.. (2011). Identification of QTL genes for BMD variation using both linkage and gene-based association approaches. Bone. 48. S153–S153. 1 indexed citations
6.
Xiao, Shenglan, Yang Gao, Ching‐Lung Cheung, et al.. (2011). Association of Cdx1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Bone. 48. S158–S159. 1 indexed citations
7.
Chan, Belinda, K.S. Lau, Bei Jiang, et al.. (2008). Ethanolic extract of Actaea racemosa (black cohosh) potentiates bone nodule formation in MC3T3-E1 preosteoblast cells. Bone. 43(3). 567–573. 21 indexed citations
8.
Kung, Annie W. C., K.S. Lau, William M.W. Cheung, & Vivian Chan. (2006). Thyrotoxic periodic paralysis and polymorphisms of sodium–potassium ATPase genes. Clinical Endocrinology. 64(2). 158–161. 20 indexed citations
9.
Kung, Annie W.C., K.S. Lau, G.C.Y. Fong, & Vivian Chan. (2004). Association of Novel Single Nucleotide Polymorphisms in the Calcium Channel α1 Subunit Gene (Cav1.1) and Thyrotoxic Periodic Paralysis. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1340–1345. 58 indexed citations
10.
Kung, Annie W. C., K.S. Lau, & Leonard D. Kohn. (2001). Epitope Mapping of TSH Receptor-Blocking Antibodies in Graves’ Disease That Appear during Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 86(8). 3647–3653. 29 indexed citations
11.
Kung, Annie W.C., K.S. Lau, & Leonard D. Kohn. (2000). Characterization of Thyroid-Stimulating Blocking Antibodies That Appeared During Transient Hypothyroidism After Radioactive Iodine Therapy. Thyroid. 10(10). 909–917. 13 indexed citations
12.
Kung, A W, et al.. (1998). Vitamin D Receptor Gene Polymorphisms and Peak Bone Mass In Southern Chinese Women. Bone. 22(4). 389–393. 45 indexed citations
13.
Kung, Annie W. C. & K.S. Lau. (1998). Gamma-interferon activates a nuclear protein that binds to the gamma-interferon activation site of the thyroglobulin gene. Journal of Molecular Endocrinology. 20(3). 293–298. 5 indexed citations
14.
Lung, Maria Li, et al.. (1992). Incidence ofras oncogene activation in lung carcinomas in Hong Kong. Cancer. 70(4). 760–763. 26 indexed citations
15.
Kung, Annie W. C., Lingyu Ma, & K.S. Lau. (1992). The role of interferon-gamma in lymphocytic thyroiditis: its functional and pathological effect on human thyrocytes in culture. Clinical & Experimental Immunology. 87(2). 261–265. 10 indexed citations
16.
Kung, Annie W. C. & K.S. Lau. (1990). Interferon-γ Inhibits Thyrotropin-Induced Thyroglobulin Gene Transcription in Cultured Human Thyrocytes*. The Journal of Clinical Endocrinology & Metabolism. 70(6). 1512–1517. 24 indexed citations
17.
Lau, K.S., et al.. (1990). Interleukin-1β Modulates Thyrotropin-Induced Thyroglobulin mRNA Transcription through 3′,5′-Cyclic Adenosine Monophosphate*. Endocrinology. 127(3). 1369–1374. 10 indexed citations
18.
Lau, K.S., et al.. (1981). The australasian reference thromboplastin: I. A Study in bleeding patients. Pathology. 13(3). 525–535. 3 indexed citations
19.
Lau, K.S., et al.. (1981). The australasian reference thromboplastin: II. Are corrected prothrombin ratios valid?. Pathology. 13(3). 537–542. 2 indexed citations
20.
Mukherjee, Anirban, et al.. (1970). Vascular Complications in Nephrotic Syndrome: Relationship to Steroid Therapy and Accelerated Thromboplastin Generation. BMJ. 4(5730). 273–276. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Di Fulvio Breakdown of academic impact, for papers by S. Yumita Breakdown of academic impact, for papers by Nobuo Kotajima Breakdown of academic impact, for papers by Anna‐Lena Eriksson Breakdown of academic impact, for papers by Laura Fazzuoli Breakdown of academic impact, for papers by H Nihei Breakdown of academic impact, for papers by Katharina I. Blankenstein Breakdown of academic impact, for papers by María G. Ledesma-Colunga Breakdown of academic impact, for papers by F. Archambeaud Breakdown of academic impact, for papers by Naoko Amano
Rankless by CCL
2026